ZPHC Tirzepatide AQ pen 30 mg

ZPHC Tirzepatide AQ Pen 30 mg — Effective weight loss & blood sugar control

This proven medicine (Mounjaro, Zepbound) helps your body control blood sugar and supports steady weight loss by working with your natural hormones.

How it works

Dual action: Signals your body to release insulin, reduces blood sugar, and tells your brain you’re satisfied—so you eat less and lose weight naturally.

Your dosing schedule

• Weeks 1–4: 2.5 mg per week
• Weeks 5–8: 5 mg per week
• Weeks 9–12: 7.5 mg per week
• Weeks 13–16: 10 mg per week

Optional: 12.5 mg for 4 weeks, then 15 mg weekly (standard maintenance). Most people see results in 12–24 weeks.

What to expect

Common side effects: Nausea, vomiting, diarrhea, constipation. Usually fade within a few weeks. Start slowly with doses and eat balanced meals.

Serious (rare): Severe belly pain, persistent vomiting, pancreas inflammation. Stop and contact your doctor immediately.

Not for you if: Pregnant, breastfeeding, or have medullary thyroid cancer or MEN 2 syndrome history.

Getting started

• Medical check-up — Confirm it’s safe for you
• Baseline measurements — Record weight, blood sugar, kidney function
• Follow-up support — Regular monitoring and guidance

We recommend using a peptide dosage and reconstitution calculator to determine how many pens you’ll need for your cycle.